IndraLab

Statements


| 1

reach
"Sulfonylurea drugs seem to specifically inhibit the triggering step of NLRP3 activation without affecting the NF-kappaB signaling related priming step or the activation of other inflammasomes XREF_BIBR, XREF_BIBR."